{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:53:21Z","timestamp":1792792401423,"version":"4.5.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Neurocrine Biosciences, Inc","id":[{"id":"https:\/\/ror.org\/05d84mm26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2021,4,3]]},"DOI":"10.1080\/14737175.2021.1898948","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T06:45:27Z","timestamp":1615185927000},"page":"393-404","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":48,"title":["Clinical development of valbenazine for tics associated with Tourette syndrome"],"prefix":"10.1080","volume":"21","author":[{"given":"Robert H.","family":"Farber","sequence":"first","affiliation":[{"name":"Medical Affairs, Neurocrine Biosciences, Inc., San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Angelov","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurocrine Biosciences, Inc., San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Kim","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurocrine Biosciences, Inc., San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Carmack","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurocrine Biosciences, Inc., San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Thai-Cuarto","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurocrine Biosciences, Inc., San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiry","family":"Roberts","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurocrine Biosciences, Inc., San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-020-00914-6","volume":"17","author":"Billnitzer A","year":"2020","journal-title":"Neurotherapeutics"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0486-0"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2019-12-2"},{"key":"cit0004","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2013","edition":"5"},{"issue":"5","key":"cit0005","first-page":"401","volume":"25","author":"Seideman MF","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2650"},{"key":"cit0007","first-page":"240","volume":"96","author":"Scahill L","year":"2005","journal-title":"Adv Neurol"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0000000000000550"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1080\/15374410701279545"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.04.027"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1002\/da.22357"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0150-11.2011"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182104106"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00052-F"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1993.64"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00428-6"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007466"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007467"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-011-0163-7"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30152-8"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01416.x"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.201711980"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/med.20187"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.10.5166"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1455504"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1258063"},{"key":"cit0027","unstructured":"Ingrezza [Prescribing Information]. San Diego (CA): Neurocrine Biosciences; 2020. [cited 2021 Mar 1]. Available from: https:\/\/www.neurocrine.com\/assets\/INGREZZA-full-Prescribing-Information.pdf."},{"key":"cit0028","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.116.239160","volume":"361","author":"Grigoriadis DE","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmch.2017.12.002"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1997)9:1<59::AID-CHIR11>3.0.CO;2-P"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0202-z"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198907000-00015"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26330"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16091037"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11777"},{"key":"cit0036","unstructured":"Orap [Prescribing Information]. Sellersville (PA): Teva Pharmaceuticals USA; 2008."},{"key":"cit0037","unstructured":"Abilify [Prescribing Information]. Tokyo, Japan: Otsuka America Pharmaceutical Inc; 2016."},{"key":"cit0038","unstructured":"Haloperidol. 2018 [cited 2018 Oct 31]. Available from: https:\/\/www.drugs.com\/monograph\/haloperidol.html"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23894"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000326"},{"issue":"1","key":"cit0041","first-page":"9","volume":"5","author":"Kenney CJ","year":"2007","journal-title":"J Pediatr Neurol"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200828070-00006"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.287"},{"key":"cit0044","unstructured":"Teva announces registration trials of deutetrabenazine in pediatric patients with tourette syndrome did not meet the primary endpoint. Press Release, 2020 Feb 19. Available from: https:\/\/www.tevapharm.com\/news-and-media\/latest-news\/teva-announces-registration-trials-of-deutetrabenazine-in-pediatric-patients-with-tourette-syndrome-did-n\/."}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2021.1898948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T13:48:07Z","timestamp":1619963287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2021.1898948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,3]]}},"alternative-id":["10.1080\/14737175.2021.1898948"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2021.1898948","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}